Cargando…

Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model

Recently, several studies have demonstrated that intravenous administration of mesenchymal stem cells (MSCs) improve medication‐related osteonecrosis of the jaw (MRONJ), and paracrine effects of secretomes from MSCs have been hypothesized as the primary contributors. These secretomes in conditioned...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Kenichi, Matsumura, Mayu, Moriyama, Masafumi, Katagiri, Wataru, Hibi, Hideharu, Nakamura, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124208/
https://www.ncbi.nlm.nih.gov/pubmed/30283893
http://dx.doi.org/10.1002/jbm4.10013
_version_ 1783352994048245760
author Ogata, Kenichi
Matsumura, Mayu
Moriyama, Masafumi
Katagiri, Wataru
Hibi, Hideharu
Nakamura, Seiji
author_facet Ogata, Kenichi
Matsumura, Mayu
Moriyama, Masafumi
Katagiri, Wataru
Hibi, Hideharu
Nakamura, Seiji
author_sort Ogata, Kenichi
collection PubMed
description Recently, several studies have demonstrated that intravenous administration of mesenchymal stem cells (MSCs) improve medication‐related osteonecrosis of the jaw (MRONJ), and paracrine effects of secretomes from MSCs have been hypothesized as the primary contributors. These secretomes in conditioned media from human MSCs (MSC‐CM) were previously demonstrated to promote bone and tissue regeneration. Because MSC‐CM contain cytokines monocyte chemoattractant protein (MCP)‐1, insulin growth factor (IGF)‐1, and vascular endothelial growth factor (VEGF) at relatively higher concentrations than other factors, these cytokines were considered as relevant active factors for tissue regeneration. By mixing the recombinant proteins of MCP‐1, IGF‐1, and VEGF, included at the same concentrations in MSC‐CM, we prepared cytokine mixtures mimicking MSC‐CM and then evaluated its therapeutic effects in a rat MRONJ model. In vitro, cytokine mixtures promoted osteogenic differentiation, migration, and proliferation of rat MSCs. In addition, these maintained osteoclastic function. In vivo, we used a rat MRONJ model to examine therapeutic effects of the cytokine mixtures through intravenous administration. In MSC‐CM or cytokine mixture group, open alveolar sockets in 66% or 67% of the rats with MRONJ, respectively, healed with complete soft tissue coverage and socket bones, whereas in the other groups, the exposed necrotic bone with inflamed soft tissue remained. Histological analysis revealed new bone formation and the appearance of osteoclasts in MSC‐CM or cytokine mixture group; however, osteoclasts were significantly reduced in the other groups. Thus, we concluded that intravenous administration of cytokine mixtures might be an effective therapeutic modality for treating patients with MRONJ. © 2017 The Authors JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research
format Online
Article
Text
id pubmed-6124208
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61242082018-10-03 Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model Ogata, Kenichi Matsumura, Mayu Moriyama, Masafumi Katagiri, Wataru Hibi, Hideharu Nakamura, Seiji JBMR Plus Original Articles Recently, several studies have demonstrated that intravenous administration of mesenchymal stem cells (MSCs) improve medication‐related osteonecrosis of the jaw (MRONJ), and paracrine effects of secretomes from MSCs have been hypothesized as the primary contributors. These secretomes in conditioned media from human MSCs (MSC‐CM) were previously demonstrated to promote bone and tissue regeneration. Because MSC‐CM contain cytokines monocyte chemoattractant protein (MCP)‐1, insulin growth factor (IGF)‐1, and vascular endothelial growth factor (VEGF) at relatively higher concentrations than other factors, these cytokines were considered as relevant active factors for tissue regeneration. By mixing the recombinant proteins of MCP‐1, IGF‐1, and VEGF, included at the same concentrations in MSC‐CM, we prepared cytokine mixtures mimicking MSC‐CM and then evaluated its therapeutic effects in a rat MRONJ model. In vitro, cytokine mixtures promoted osteogenic differentiation, migration, and proliferation of rat MSCs. In addition, these maintained osteoclastic function. In vivo, we used a rat MRONJ model to examine therapeutic effects of the cytokine mixtures through intravenous administration. In MSC‐CM or cytokine mixture group, open alveolar sockets in 66% or 67% of the rats with MRONJ, respectively, healed with complete soft tissue coverage and socket bones, whereas in the other groups, the exposed necrotic bone with inflamed soft tissue remained. Histological analysis revealed new bone formation and the appearance of osteoclasts in MSC‐CM or cytokine mixture group; however, osteoclasts were significantly reduced in the other groups. Thus, we concluded that intravenous administration of cytokine mixtures might be an effective therapeutic modality for treating patients with MRONJ. © 2017 The Authors JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research John Wiley and Sons Inc. 2017-09-06 /pmc/articles/PMC6124208/ /pubmed/30283893 http://dx.doi.org/10.1002/jbm4.10013 Text en © 2017 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ogata, Kenichi
Matsumura, Mayu
Moriyama, Masafumi
Katagiri, Wataru
Hibi, Hideharu
Nakamura, Seiji
Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title_full Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title_fullStr Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title_full_unstemmed Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title_short Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
title_sort cytokine mixtures mimicking secretomes from mesenchymal stem cells improve medication‐related osteonecrosis of the jaw in a rat model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124208/
https://www.ncbi.nlm.nih.gov/pubmed/30283893
http://dx.doi.org/10.1002/jbm4.10013
work_keys_str_mv AT ogatakenichi cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel
AT matsumuramayu cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel
AT moriyamamasafumi cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel
AT katagiriwataru cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel
AT hibihideharu cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel
AT nakamuraseiji cytokinemixturesmimickingsecretomesfrommesenchymalstemcellsimprovemedicationrelatedosteonecrosisofthejawinaratmodel